CPT® Code 86256 is used to report antibody titer testing using fluorescent techniques for noninfectious antigens, with the code reported for each antibody tested. This type of testing is commonly used in the evaluation of autoimmune and immune-mediated disorders, where determining the concentration (titer) of specific antibodies can aid in diagnosis and disease monitoring.
This code represents the titer determination itself, typically following an initial positive antibody screen.
Key Facts About CPT® 86256
- Service type: Laboratory test (immunology/autoimmune testing)
- Test: Fluorescent antibody titer for a noninfectious antigen
- Reporting: Per antibody tested
- Method: Indirect fluorescent antibody (IFA) technique
- Specimen type: Serum
- Provider type: Laboratories, physicians, and qualified healthcare professionals
Common clinical indications:
- Evaluation of autoimmune diseases
- Confirmation of positive antibody screening results
- Monitoring autoimmune disease activity
- Rheumatologic disorder workups
- Assessment of immune-mediated conditions
When to Use CPT® 86256
CPT 86256 is appropriate when:
- Performing fluorescent antibody titer testing for a noninfectious antigen
- Determining the concentration of a previously identified antibody
- Evaluating suspected autoimmune disease
- Monitoring antibody levels over time for disease management
Examples:
- Determining ANA titers following a positive antinuclear antibody screen
- Measuring antibody levels in patients with suspected autoimmune disorders
- Monitoring changes in antibody titers during treatment
- Performing follow-up testing after abnormal immunologic screening results
Documentation Requirements
To support CPT 86256 billing, documentation should include:
- Patient identifiers and date of service
- Clinical indication for testing
- Specific antibody being evaluated
- Specimen type (typically serum)
- Testing methodology (fluorescent antibody titer)
- Titer result and date reported
- Ordering provider information
Documentation should clearly identify each antibody tested, as the code is reported per antibody.
Reimbursement and Coding Considerations
- CPT 86256 is reported for each antibody titer performed
- Often billed in conjunction with antibody screening tests when clinically appropriate
- Diagnosis coding should support autoimmune, rheumatologic, or immune-related conditions
- Coverage is generally dependent on medical necessity and clinical indication
- Frequency limitations may apply based on payer policies and disease monitoring guidelines
Always verify payer-specific immunology and laboratory billing requirements.
How OptiMantra Supports Autoimmune and Immunology Testing
OptiMantra’s integrated EMR and practice management system streamlines documentation and billing for CPT 86256:
With OptiMantra, providers can:
- Order autoimmune and antibody testing within the patient chart
- Track antibody titers and other laboratory values over time
- Link results to diagnoses, treatment plans, and follow-up care
- Maintain organized laboratory documentation that supports billing compliance and audit preparedness
- Integrate specialty laboratory workflows into a centralized patient record
By centralizing immunology testing workflows, OptiMantra helps practices improve efficiency, ensure compliance, and optimize reimbursement.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
